Condition
End-Stage Kidney Disease (ESKD) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 End-Stage Kidney Disease (ESKD) clinical trials that are recruiting, at sites in 4 countries (most in Canada (1), United States (1), Belgium (1)). 1 was first registered in the last 30 days. By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1New in 30 days
- 4Countries
Newest End-Stage Kidney Disease (ESKD) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Guiding Optimal Blood Pressure in Peritoneal Dialysis | — | San Francisco, California and 2 other locations | Recruiting | Nov 2, 2026 |
| Three antibodies plus heparin in adults with end-stage kidney disease on dialysis | Phase 1 | Ghent, Oost-Vlaanderen | Recruiting | Aug 12, 2026 |
| CSL300 in Chinese adults with End Stage Kidney Disease on dialysis | Phase 1 | Beijing | Recruiting | Jun 2, 2026 |
| Dialysis that removes more middle molecules using super high‑flux filters | — | London, Ontario and 2 other locations | Recruiting | Oct 28, 2024 |
All recruiting trials (4)
-
Guiding Optimal Blood Pressure in Peritoneal Dialysis
This pilot tests whether aiming for a lower systolic blood pressure target (<120 mmHg) is feasible and practical for adults with end-stage kidney disease on peritoneal dialysis, compared to a <140 mmHg target.
-
Three antibodies plus heparin in adults with end-stage kidney disease on dialysis
This study tests three investigational antibodies (REGN9933, REGN7508, REGN9533) in adults with end-stage kidney disease on hemodialysis who are already using heparin to prevent clots.
-
CSL300 in Chinese adults with End Stage Kidney Disease on dialysis
This study tests how CSL300 behaves in the body after single and multiple doses in Chinese adults with end stage kidney disease on dialysis, compared with placebo.
-
Dialysis that removes more middle molecules using super high‑flux filters
This trial will test whether using super high‑flux (expanded) dialysis filters instead of standard high‑flux filters reduces the risk of death and other harms for adults on in‑center hemodialysis who are older or have diabetes.
Related topics
Quick answers
How many End-Stage Kidney Disease (ESKD) clinical trials are recruiting right now?
4, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Canada (1 trial), United States (1 trial), Belgium (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.